Market Place
Sourcing Support
Cogent Biosciences Presents Bezuclastinib Data at ASH 2024
05 Nov 2024 //
GLOBENEWSWIRE
Cogent Reports Additional Bezuclastinib Data In NonAdvSM
14 Jun 2024 //
GLOBENEWSWIRE
Cogent Bezuclastinib Peak Lead-In: Gist Phase 3 Positive At Asco
23 May 2024 //
GLOBENEWSWIRE
Cogent Announces Positive Part 1b Data from Trial Evaluating Bezuclastinib
22 Feb 2024 //
GLOBENEWSWIRE
Cogent Biosciences to Present SUMMIT Part 1b Data with Bezuclastinib in NonAdvSM
05 Feb 2024 //
GLOBENEWSWIRE
Cogent Biosciences Announces Planned 2024 Milestones for Bezuclastinib
09 Jan 2024 //
GLOBENEWSWIRE
Cogent Announces Positive Data from Phase 2 APEX Trial Evaluating Bezuclastinib
11 Dec 2023 //
GLOBENEWSWIRE
Cogent Announces Positive Data from Phase 2 Trial Evaluating Bezuclastinib
09 Dec 2023 //
GLOBENEWSWIRE
Cogent Bio Announces Positive Lead-In Data from Ongoing Phase 3 PEAK Trial
03 Jun 2023 //
GLOBENEWSWIRE
Cogent Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial
11 Dec 2022 //
GLOBENEWSWIRE
Cogent Biosciences to Host Investor Webcast to Discuss Clinical Data at ASH
05 Dec 2022 //
BIOSPACE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.